Apyx Medical vs Shoulder Innovations
Apyx Medical and Shoulder Innovations are similar in size: $52.8m and $47.3m of revenue in their latest fiscal years. Shoulder Innovations grew faster (49.6% against 9.9%). Apyx Medical kept more of each dollar of sales as profit: a net margin of -21.2% against -85.3%.
| Latest fiscal year | Apyx MedicalAPYX, 2025 | Shoulder InnovationsSI, 2025 |
|---|---|---|
| Revenue | $52.8m | $47.3m |
| Revenue growth | 9.9% | 49.6% |
| Net income | −$11.2m | −$40.4m |
| Operating margin | — | -55.6% |
| Net margin | -21.2% | -85.3% |
| Return on equity | -78.0% | -93.8% |
| Free cash flow | −$9.1m | −$36.0m |
| Cash | $31.7m | $26.9m |
| Total debt | $37.5m | $14.9m |
| Debt to equity | — | 10.6% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 205 | 75 |
| Market value | $108m | $405m |
| Price vs our value range | — | — |
| Moat score | 44 (Weak) | — |
| Insider trades, 12 months | 0 buys, 0 sales | 7 buys, 17 sales |